XpresSpa Group Signs Contract with Metropolitan Washington Airports Authority for XpresCheck™ COVID-19 Testing Facilities a...
19 February 2021 - 12:30AM
XpresSpa Group, Inc. (Nasdaq: XSPA) (“XpresSpa” or the “Company”),
a health and wellness company, today announced that it has signed a
contract with Metropolitan Washington Airports Authority for
XpresCheck™ COVID-19 Testing Facilities at Dulles International
Airport and Reagan National Airport. Both of these locations are
expected to be fully operational by mid-March.
At Dulles International Airport, XpresCheck will
be building a pop-up facility located in the Main International
Terminal, pre-security. This facility will host nine separate
testing rooms with an anticipated capacity to administer over 500
tests per day. COVID-19 testing options will include the Rapid
Molecular COVID-19 Test and the Polymerase Chain Reaction (PCR)
Test.
At Reagan National Airport, XpresCheck will be
building a pop-up facility in their
existing XpresSpa location at National Hall,
pre-security. This facility will host four separate testing rooms
with an anticipated capacity to administer over 300 tests per day.
COVID-19 testing options will include the Rapid Molecular COVID-19
Test and the Polymerase Chain Reaction (PCR) Test.
Doug Satzman, XpresSpa CEO, stated, "We are
excited to be expanding XpresCheck to the metro Washington DC
region by opening at both Dulles International and Reagan National
next month. We recognize the important role our COVID-19 testing
facilities play in supporting domestic and international air travel
by ensuring airport employees and travelers feel safe and confident
when traveling through our nation’s capital.”
About XpresSpa Group, Inc.
XpresSpa Group, Inc. (Nasdaq: XSPA) is a leading
global health and wellness holding company. XpresSpa Group’s core
asset, XpresSpa, is a leading airport retailer of spa services and
related health and wellness products, with 45 locations in 23
airports globally. Through its XpresTest, Inc. subsidiary, the
Company provides COVID-19 screening and testing under the
XpresCheck™ brand at eight locations in six airports: Denver
International Airport, JFK International Airport, Boston Logan
International Airport (2), Newark Liberty International Airport
(2), Phoenix Sky Harbor International Airport, and Salt Lake City
International Airport. To learn more about XpresSpa Group, visit:
www.XpresSpaGroup.com.
Twitter: @xprescheck and Instagram:
@realxprescheck
Forward-Looking StatementsThis
press release may contain "forward-looking" statements within the
meaning of Section 27A of the Securities Act of 1933, and Section
21E of the Securities Exchange Act of 1934. These include
statements preceded by, followed by or that otherwise include the
words "believes," "expects," "anticipates," "estimates,"
"projects," "intends," "should," "seeks," "future," "continue," or
the negative of such terms, or other comparable terminology. In
particular, these statements include, without limitation,
statements about our expectations relating to our new XpresCheck™
concept, being able to expand testing to other communicable
diseases as well as administer vaccinations for the seasonal flu,
our positioning to be part of the national rollout of various
COVID-19 vaccinations as they become available, the degree to which
our public testing model assists passengers meet testing
requirements in select states and countries, our ability to
identify and gain access to the latest and best COVID-19 testing
methodologies and equipment, and our ability further expand our
initial sites and our overall ability to manage the regulatory
challenges associated with this business line. Forward-looking
statements relating to expectations about future results or events
are based upon information available to XpresSpa Group as of
today's date and are not guarantees of the future performance of
the company, and actual results may vary materially from the
results and expectations discussed. Additional information
concerning these and other risks is contained in XpresSpa Group’s
most recently filed Annual Report on Form 10-K, Quarterly Report on
Form 10-Q, recent Current Reports on Form 8-K and other Securities
and Exchange Commission filings. All subsequent written and oral
forward-looking statements concerning XpresSpa Group, or other
matters and attributable to XpresSpa Group or any person acting on
its behalf are expressly qualified in their entirety by the
cautionary statements above. XpresSpa Group does not undertake any
obligation to publicly update any of these forward-looking
statements to reflect events or circumstances that may arise after
the date hereof.
Investor Relations:ICRRaphael
Grossir@xpresspagroup.com (203) 682-8253
MediaJulie FergusonJulie@jfprmedia.com(312)
385-0098
XpresSpa (NASDAQ:XSPA)
Historical Stock Chart
From Apr 2024 to May 2024
XpresSpa (NASDAQ:XSPA)
Historical Stock Chart
From May 2023 to May 2024